Atlas Trials

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Clinical trial NCT02673476 · COMPLETED

Trial details

NCT number
NCT02673476
Sponsor
Alios Biopharma Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infections
Start date
2016-02-29
Primary completion
2016-10-31
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.